-
Oxyntomodulin (often
abbreviated OXM) is a
naturally occurring 37-amino acid
peptide hormone found in the colon,
produced by the
oxyntic (fundic) cells...
-
Glicentin (21–89) Glicentin-related
pancreatic polypeptide (GRPP, 21-50)
Oxyntomodulin (OXY or OXM, 53–89)
Glucagon (53–81) Glucagon-like
peptide 1 (GLP-1...
- GLP-1/glucagon dual agonists, it is a
glucagon analog rather than an
analog of
oxyntomodulin. It is
developed by
Boehringer Ingelheim as a
weight loss drug. Klein...
-
agonist of the GLP-1
receptor and
glucagon receptor. It is an
analog of
oxyntomodulin (OXM). The drug is
developed by Eli
Lilly and is
currently in multiple...
- commercially-available kits for
glucagon and
oxyntomodulin found that the
MyBioSource ****ay (MBS701592) for
detecting oxyntomodulin "yielded
inconsistent results"....
- an
acute influence on food
intake through its
effects on
adipocytes Oxyntomodulin plays a role in
controlling acid
secretion and
satiation Hormone, endocrine...
-
giving rise to glicentin,
which may be
further processed to GRPP and
oxyntomodulin, GLP-1,
intervening peptide-2 (IP-2) and glucagon-like peptide-2 (GLP-2)...
-
cells secrete glucagon-like peptide-1, an incretin,
peptide YY3-36,
oxyntomodulin and glucagon-like peptide-2. L cells are
primarily found in the ileum...
-
Enteroendocrine cell L cell glucagon-like peptide-1,
peptide YY3-36,
oxyntomodulin, and glucagon-like peptide-2)
secretion I cell
cholecystokinin (CCK)...
- Han; Wenxi, Wang; Bhawal,
Ruchika (April 2023). "Emerging
roles of
oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist
analogs in diabetes...
